Rajesh Kumar
Stock Analyst at HSBC
(4.39)
# 1,174
Out of 4,421 analysts
148
Total ratings
63.6%
Success rate
14.4%
Average return
Main Sectors:
Stocks Rated by Rajesh Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €390.00 → €230.00 | $165.50 | +38.97% | 2 | Jun 3, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 680.00 → CHF 590.00 | $491.60 | +20.02% | 3 | Jun 3, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | $53 → $60 | $54.00 | +11.11% | 8 | Mar 17, 2026 | |
| LLY Eli Lilly and Company | Maintained: Sell | $850 | $1,098.57 | -22.63% | 9 | Mar 17, 2026 | |
| PFE Pfizer | Maintained: Buy | $32 | $25.21 | +26.93% | 6 | Mar 17, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 300.00 → kr 280.00 | $279.92 | +0.03% | 3 | Mar 17, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Sell | CHF 82.00 → CHF 95.00 | $118.04 | -19.52% | 4 | Mar 17, 2026 | |
| ABBV AbbVie | Maintained: Buy | $265 | $216.49 | +22.41% | 9 | Jan 9, 2026 | |
| MRK Merck & Co. | Maintained: Buy | $120 | $113.87 | +5.38% | 5 | Dec 10, 2025 | |
| NVS Novartis AG | Maintained: Sell | $88 → $112 | $147.08 | -23.85% | 2 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $70 → $54 | $43.19 | +25.03% | 4 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $57 | $49.74 | +14.60% | 3 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | 1,170p → 1,500p | $1,923.00 | -22.00% | 3 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €32.00 → €40.00 | $37.15 | +7.67% | 8 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €115.00 → €100.00 | $73.34 | +36.35% | 4 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $453 | $162.68 | +178.76% | 1 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 | $42.38 | +170.42% | 1 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | CHF 295.00 → CHF 320.00 | $319.00 | +0.31% | 3 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $20 | $31.48 | n/a | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 3,320 → kr 1,990 | $1,614.50 | n/a | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €101.00 → €179.00 | $249.31 | n/a | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $82 | $123.76 | n/a | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $270 | $167.77 | n/a | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $660 → $670 | $464.61 | n/a | 3 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $230 → $280 | $177.17 | n/a | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $69 → $86 | $63.96 | n/a | 3 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 → $233 | $238.35 | n/a | 6 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €170.00 | $133.05 | n/a | 3 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $124 → $111 | $90.89 | n/a | 2 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 260.00 | $440.20 | n/a | 1 | Sep 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 13,250p | $13,154.00 | n/a | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | 200p | $206.00 | n/a | 1 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | €33.00 | $41.26 | n/a | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 7,900p → 6,565p | $6,155.00 | n/a | 4 | Dec 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 3,050p → 2,880p | $2,494.00 | n/a | 3 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | 6,440p → 5,700p | $5,815.00 | n/a | 2 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €32.00 → €31.00 | $26.21 | n/a | 5 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | €76.00 → €92.00 | $62.88 | n/a | 2 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 3,300 → CHF 2,860 | $91.40 | n/a | 5 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 685p | $863.60 | n/a | 1 | Jan 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €92.00 → €96.00 | $53.96 | n/a | 7 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €137.00 → €195.00 | $83.90 | n/a | 4 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 3,200p | $2,509.00 | n/a | 1 | Mar 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | 625p → 1,000p | $620.00 | n/a | 3 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $33.10 | n/a | 1 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 1,370p | $7,135.00 | n/a | 1 | Apr 6, 2020 |
Sartorius Stedim Biotech S.A.
Jun 3, 2026
Maintained: Buy
Price Target: €390.00 → €230.00
Current: $165.50
Upside: +38.97%
Lonza Group AG
Jun 3, 2026
Maintained: Buy
Price Target: CHF 680.00 → CHF 590.00
Current: $491.60
Upside: +20.02%
Bristol-Myers Squibb Company
Mar 17, 2026
Maintained: Hold
Price Target: $53 → $60
Current: $54.00
Upside: +11.11%
Eli Lilly and Company
Mar 17, 2026
Maintained: Sell
Price Target: $850
Current: $1,098.57
Upside: -22.63%
Pfizer
Mar 17, 2026
Maintained: Buy
Price Target: $32
Current: $25.21
Upside: +26.93%
Novo Nordisk A/S
Mar 17, 2026
Maintained: Hold
Price Target: kr 300.00 → kr 280.00
Current: $279.92
Upside: +0.03%
Novartis AG
Mar 17, 2026
Maintained: Sell
Price Target: CHF 82.00 → CHF 95.00
Current: $118.04
Upside: -19.52%
AbbVie
Jan 9, 2026
Maintained: Buy
Price Target: $265
Current: $216.49
Upside: +22.41%
Merck & Co.
Dec 10, 2025
Maintained: Buy
Price Target: $120
Current: $113.87
Upside: +5.38%
Novartis AG
Dec 10, 2025
Maintained: Sell
Price Target: $88 → $112
Current: $147.08
Upside: -23.85%
Dec 10, 2025
Maintained: Hold
Price Target: $70 → $54
Current: $43.19
Upside: +25.03%
Dec 10, 2025
Maintained: Buy
Price Target: $57
Current: $49.74
Upside: +14.60%
Dec 10, 2025
Maintained: Sell
Price Target: 1,170p → 1,500p
Current: $1,923.00
Upside: -22.00%
Dec 10, 2025
Maintained: Buy
Price Target: €32.00 → €40.00
Current: $37.15
Upside: +7.67%
Dec 10, 2025
Maintained: Buy
Price Target: €115.00 → €100.00
Current: $73.34
Upside: +36.35%
Dec 2, 2025
Maintained: Buy
Price Target: $453
Current: $162.68
Upside: +178.76%
Dec 2, 2025
Maintained: Buy
Price Target: $115
Current: $42.38
Upside: +170.42%
Oct 1, 2025
Upgraded: Buy
Price Target: CHF 295.00 → CHF 320.00
Current: $319.00
Upside: +0.31%
Apr 28, 2025
Maintained: Buy
Price Target: $13 → $20
Current: $31.48
Upside: n/a
Apr 28, 2025
Maintained: Buy
Price Target: kr 3,320 → kr 1,990
Current: $1,614.50
Upside: n/a
Apr 28, 2025
Maintained: Buy
Price Target: €101.00 → €179.00
Current: $249.31
Upside: n/a
Dec 4, 2024
Maintained: Hold
Price Target: $82
Current: $123.76
Upside: n/a
Dec 4, 2024
Maintained: Buy
Price Target: $270
Current: $167.77
Upside: n/a
Apr 30, 2024
Maintained: Buy
Price Target: $660 → $670
Current: $464.61
Upside: n/a
Apr 16, 2024
Upgraded: Buy
Price Target: $230 → $280
Current: $177.17
Upside: n/a
Feb 26, 2024
Downgraded: Sell
Price Target: $69 → $86
Current: $63.96
Upside: n/a
Feb 14, 2024
Maintained: Buy
Price Target: $180 → $233
Current: $238.35
Upside: n/a
Dec 18, 2023
Upgraded: Buy
Price Target: €170.00
Current: $133.05
Upside: n/a
Oct 16, 2023
Downgraded: Hold
Price Target: $124 → $111
Current: $90.89
Upside: n/a
Sep 1, 2023
Maintained: Buy
Price Target: kr 260.00
Current: $440.20
Upside: n/a
Jul 14, 2023
Initiated Coverage: Buy
Price Target: 13,250p
Current: $13,154.00
Upside: n/a
Mar 22, 2023
Maintained: Sell
Price Target: 200p
Current: $206.00
Upside: n/a
Mar 7, 2023
Downgraded: Sell
Price Target: €33.00
Current: $41.26
Upside: n/a
Dec 9, 2022
Maintained: Buy
Price Target: 7,900p → 6,565p
Current: $6,155.00
Upside: n/a
Oct 20, 2022
Maintained: Hold
Price Target: 3,050p → 2,880p
Current: $2,494.00
Upside: n/a
Apr 8, 2022
Downgraded: Hold
Price Target: 6,440p → 5,700p
Current: $5,815.00
Upside: n/a
Apr 8, 2022
Maintained: Buy
Price Target: €32.00 → €31.00
Current: $26.21
Upside: n/a
Apr 8, 2022
Upgraded: Hold
Price Target: €76.00 → €92.00
Current: $62.88
Upside: n/a
Apr 8, 2022
Downgraded: Hold
Price Target: CHF 3,300 → CHF 2,860
Current: $91.40
Upside: n/a
Jan 26, 2022
Maintained: Buy
Price Target: 685p
Current: $863.60
Upside: n/a
Sep 28, 2021
Maintained: Buy
Price Target: €92.00 → €96.00
Current: $53.96
Upside: n/a
Sep 28, 2021
Maintained: Buy
Price Target: €137.00 → €195.00
Current: $83.90
Upside: n/a
Mar 19, 2021
Maintained: Buy
Price Target: 3,200p
Current: $2,509.00
Upside: n/a
Jan 13, 2021
Upgraded: Buy
Price Target: 625p → 1,000p
Current: $620.00
Upside: n/a
May 6, 2020
Upgraded: Buy
Price Target: n/a
Current: $33.10
Upside: n/a
Apr 6, 2020
Maintained: Hold
Price Target: 1,370p
Current: $7,135.00
Upside: n/a